SEI Investments’s Vir Biotechnology VIR Stock Holding History

SEI Investments's VIR Position: Q2 2026 in Review

SEI Investments increased its Vir Biotechnology (VIR) stake by 165% in Q2 2026, buying an estimated $553K and bringing the position to 93,333 shares worth $951K. The position accounts for ﹤0.01% of the portfolio, ranked #2320.

SEI Investments first reported a position in VIR in Q4 2024 and has held it in 7 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

• SEI Investments held 93,333 shares of Vir Biotechnology worth $951K as of Q2 2026.
• SEI Investments bought 58,131 Vir Biotechnology shares in Q2 2026, an estimated $553K.
• Vir Biotechnology made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2320 holding.
• SEI Investments first reported a position in Vir Biotechnology in Q4 2024 and has held it in 7 quarters since.
• 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.